Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
what is the downside of pcsk9 inhibitors | 1.72 | 0.5 | 7389 | 92 | 40 |
what | 0.13 | 0.4 | 3922 | 72 | 4 |
is | 0.24 | 1 | 4050 | 26 | 2 |
the | 1.14 | 0.6 | 2109 | 17 | 3 |
downside | 0.82 | 0.5 | 1322 | 97 | 8 |
of | 1.46 | 0.6 | 8186 | 70 | 2 |
pcsk9 | 0.26 | 0.6 | 6814 | 29 | 5 |
inhibitors | 1.83 | 0.4 | 5060 | 46 | 10 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
what is the downside of pcsk9 inhibitors | 0.45 | 0.8 | 4298 | 62 |
adverse effects of pcsk9 inhibitors | 1.63 | 0.4 | 1347 | 69 |
side effects of pcsk9 inhibitors | 0.62 | 0.6 | 9698 | 67 |
pcsk9 inhibitors side effects discussion | 1.96 | 0.1 | 6689 | 9 |
are pcsk9 inhibitors safe | 1.41 | 0.1 | 4657 | 65 |
what is pcsk9 inhibitors | 0.12 | 0.9 | 1300 | 25 |
pcsk9 inhibitors long term side effects | 1.91 | 0.4 | 7011 | 14 |
pcsk9 inhibitors patient information | 0.64 | 0.8 | 7875 | 37 |
examples of pcsk9 inhibitors | 0.85 | 0.9 | 39 | 13 |
list of pcsk9 inhibitor | 0.23 | 1 | 753 | 88 |
pcsk9 inhibitors and mortality benefit | 0.29 | 0.7 | 1052 | 68 |
pcsk9 inhibitors cardiovascular outcomes | 0.53 | 0.9 | 4768 | 70 |
do pcsk9 inhibitors lower lp a | 1.86 | 0.8 | 1478 | 69 |
contraindications to pcsk9 inhibitor | 0.97 | 0.3 | 2933 | 28 |